Summary
Photodynamic therapy (PDT) has been used in medicine to ablate and destroy unwanted tissue for nearly 50 years. Its unique mechanism of action is non-thermal and utilizes the activation of a photosensitizer by local application of a specific wavelength of light and the subsequent generation of oxygen radicals by the “excited” photosensitizer. These oxygen radicals create localized cellular injury and necrosis in the region of photoactivation. While a variety of photosensitizers have been studied, only porfimer sodium is approved for use in the United States. Approved gastrointestinal applications include the treatment of both squamous cell cancer and adenocarcinoma of the esophagus in non-surgical candidates for the purposes of palliation of malignant dysphagia or tumor eradication. More recently, approval for the treatment of Barrett’s esophagus with high-grade dysplasia (HGD) has been granted. The technique achieves success rates of 70–100% for these indications, but residual Barrett’s epithelium usually remains. Due to its status as the most-widely used ablation technique with more than 15 years of clinical data, PDT is the only method of ablation that has currently been shown to be durable, reduce the risk of cancer recurrence, and achieve outcomes similar to esophagectomy for the treatment of Barrett’s with HGD. Despite its high cost and known complications (development of photosensitivity reactions and esophageal strictures in nearly a third of patients), PDT appears to meet established criteria for cost-effectiveness. While initial studies of newer ablative techniques offer promising efficacy results with the advantages of cost-reduction and decreased complications, it is uncertain if these methods are durable, reduce the risk of subsequent cancer, or achieve outcomes similar to surgical therapy. Until data regarding these issues are available, PDT remains the best-validated endoscopic treatment option to surgery for patients with Barrett’s esophagus with HGD and early-stage esophageal cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang, K.K. (2001) Photodynamic therapy made simple. Clinical Persp Gastro, 90–100.
American Society of Gastrointestinal Endsoscopy. (2006) Photodynamic therapy for gastrointestinal disease. Gastrointest Endosc 63, 927–932.
Wolfsen, H.C. (2002) Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett’s esophagus. Dig Dis 20, 5–17.
Prosst, R.L., Wolfsen, H.C., and Gahlen, J. (2003) Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy 35, 1059–1068.
Overholt, B.F., Lightdale, C.J., Wang, K.K., Canto, M.I., Burdick, S., Haggitt, R.C., Bronner, M.P., Taylor, S.L., Grace, M.G.A., and Depot, M. (2005) Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62, 488–498.
Wolfsen, H., Canto, M., Etemad, B., Greenwald, B., Gress, F., Schembre, F., Muthusamy, V.R., Ribeiro, A., Sharma, V., and Ginsberg, G. (2006) Bare fiber photodynamic therapy using porfimer sodium for esophageal disease. Photodiagnosis and Photodynamic Therapy 3, 87–92.
Prasad, G.A., Wang, K.K., Buttar, N.S., Wongkeesong, L., Lutzke, L.S., and Borkenhagen, L.S. (2007) Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. Gastrointest Endosc 65, 60–66.
Savoy, A.D., Wolfsen, H.C., Raimondo, M., Woodward, T.A., Noh, K., Pungpapong, S., Hemminger, L.L., and Wallace, M.B. (2008) The role of surveillance endoscopy and endosonography after endoscopic ablation of high-grade dysplasia and carcinoma of the esophagus. Dis Esophagus 21, 108–113.
Tokar, J.L., Haluszka, O., and Weinberg, D.S. (2006) Endoscopic therapy of dysplasia and early-stage cancers of the esophagus. Semin Radiat Oncol 17, 10–21.
Ackroyd, R., Brown, N.J., Davis, M.F., Stephenson, T.J., Marcus, S.L., Stoddard, C.J., Johnson, A.G., and Reed, M.W. (2000) Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial Gut 47, 612–617.
Gossner, L., Stolte, M., Sroka, R., Rick, K., May, A., Hahn, E.G., and Ell, C. (1998) Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid. Gastroenterology 114, 448–455.
Pech, O., Gossner, L., May, A., Rabenstein, T., Vieth, M., Stolte, M., Berres, M., and Ell, C. (2005) Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62, 24–30.
Maier, A., Tomaselli, F., Matzi, V., Rehak, P., Pinter, H., and Smolle-Juttner, F.M. (2001) Does a new photosensitizer improve photodynamic therapy in advanced esophageal cancer? Lasers Surg Med 29, 323–327.
Maier, A., Tomaselli, F., Matzi, V., Rehak, P., Pinter, H., and Smolle-Juttner, F.M. (2001) Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma. Ann Thorac Surg 72, 1136–1140.
Vij, R., Triadafilopoulos, G., Owens, D.K., Kunz, P., and Sanders, G.D. (2004) Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. Gastrointest Endosc 60, 739–756.
Sibille, A., Lambert, R., Souquet, J.C., Sabben, G., and Descos, F. (1995) Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 108, 337–344.
Lightdale, C.J., Heier, S.K., Marcon, N.E., McCaughan, J.S., Gerdes, H., Overholt, B.F., Sivak, M.V., Stiegmann, G.V., and Nava, H.R. (1995) Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 42, 507–512.
Heier, S.K., Rothman, K.A., Heier, L.M., and Rosenthal, W.S. (1995) Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd: YAG laser therapy. Gastroenterology 109, 63–72.
Scheider, D.M., Siemens, M., Cirocco, M., Haber, G.B., Kandel, G., Kortan, P., and Marcon, N.E. (1997) Photodynamic therapy for the treatment of tumor ingrowth in expandable esophageal stents. Endoscopy 29, 271–274.
Wolfsen, H.C. (2005) Present status of photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. J Clin Gastroenterol 39, 189–202.
Overholt, B.F., Panjehpour, M., and Halberg, D.L. (2003) Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 58, 183–188.
Wang, K.K. (2002) Long-term follow-up after photodynamic therapy (PDT) for Barrett’s esophagus (abstract). Gastrointest Endosc 55, A599.
Overholt, B.F., Wang, K.K., Burdick, S., Lightdale, C.J., Kimmey, K., Nava, H.R., Sivak, M.V., Nishioka, N., Barr, H., Marcon, N., Pedrosa, M., Bronner, M.P., Grace, M., and Depot, M. (2007) Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc, 66, 460–468.
Li, Y., Li, L., Yu C., Liu, Y., and Xu, C. (2008) A systematic review and meta-analysis of the treatment for Barrett’s esophagus. Dig Dis Sci Nov; 53(11), 2837--2846.
Overholt, B.F., Panjehpour, M., and Haydek, J.M. (1999) Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endoscopy 49, 1–7.
Ban, S., Mino, M., Nishioka, N.S., Puricelli, W., Zukerberg, L.R., Shimizu, M., and Lauwers, G.Y. (2004) Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett’s esophagus. Am J Surg Pathol 28, 1466–1473.
Mino-Kenudson, M., Ban, S., Ohana, M., Puricelli, W., Deshpande, V., Shimizu, M., Nishioka, N.S., and Lauwers, G.Y. (2007) Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after porfimer-photodynamic therapy. Am J Surg Path 31, 403–409.
Buttar, N.S., Wang, K.K., Lutzke, L.S., Krishnadath, K.K., and Anderson, M.A. (2001) Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus. Gastrointest Endosc 54, 682–688.
Wang, K.K., and Nijhawan, P.K. (2000) Complications of photodynamic therapy in gastrointestinal disease Gastrointest Endosc Clin N Am 10, 487–495.
Ukleja, A., Scolapio, J.S., and Wolfsen, H.C. (1999) Nutritional consequences following photodynamic therapy. Gastroenterology 116, A-582.
Wang, K.K. (1999) Current status of photodynamic therapy in Barrett’s esophagus Gastrointest Endosc 49, S20–S23.
Panjehpour, M., Overholt, B.F., Haydek, J.M., and Lee, S.G. (2000) Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 95, 2177–2184.
McCaughan, J.S., Ellison, E.C., Guy, J.T., Hicks, W.J., Jones, J.J., Laufman, L.R., May, E., Nims, T.A., Spiridonidis, C.H., and Williams, T.E. (1996) Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. Ann Thorac Surg 62, 1005–1009.
Overholt, B.F., and Panjehpour, M. (1996) Photodynamic therapy for Barrett’s esophagus: clinical update. Am J Gastroenterol 91, 1719–1723.
Wolfsen, H.C., Hemminger, L.L., Wallace, M.B., and Devault, K.R. (2004) Clinical experience of patients undergoing photodynamic therapy for Barrett’s dysplasia or cancer. Aliment Pharmacol Ther 20, 1125–1131.
Yachimski, P., Puricelli, W.P., and Nishioka, N.S. (2008) Patient predictors of esophageal stricture development after photodynamic therapy. Clin Gastroenterol Hepatol 6, 302–308.
Prasad, G.A., Wang, K.K., Buttar, N.S., Wongkeesong, L., Krishnadath, K.K., Nichols, F.C., Lutzke, L.S., and Borkenhagen, L.S. (2007) Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 132, 1226–1233.
Schembre, D.B., Huang, J.L., Lin, O.S., Cantone, N., and Low, D.E. (2008) Treatment of Barrett’s esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest Endosc 67, 595–601.
Das, A., Singh, V., Fleischer, D.E., and Sharma, V.K. (2008) A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 103, 1340–1345.
Krishnadath, K.K., Wang, K.K., Taniguchi, K., Sebo, T.J., Buttar, N.S., Anderson, M.A., Lutzke, L.S., and Liu, W. (2000) Persistent genetic abnormalities in Barrett’s esophagus after photodynamic therapy. Gastroenterology 119, 624–630.
Prasad, G.A., Wang, K.K., Halling, K.C., Buttar, N.S., Wongkeesong, L., Zinsmeister, A.R., Brankley, S.M., Westra, W.M., Lutzke, L.S., and Borkenhagen, L.S., and Dunagan, K. (2008) Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus. Cancer 113, 470–476.
Prasad, G.A., Wang, K.K., Halling, K.C., Buttar, N.S., Wongkeesong, L., Zinsmeister, A.R., Brankley, S.M., Barr Fritcher, E.G., Westra, W.M., Krishnadath, K.K., Lutzke, L.S., and Borkenhagen, L.S. (2008) Utility of Biomarkers in prediction of response to ablative therapy in Barrett’s esophagus. Gastroenterology Aug, 135(2), 370--379.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Muthusamy, V.R., Chang, K.J. (2009). Photodynamic Therapy (PDT): The Best-Validated Technique. In: Sampliner, R. (eds) Endoscopic Therapy for Barrett's Esophagus. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-60327-445-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-60327-445-6_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-444-9
Online ISBN: 978-1-60327-445-6
eBook Packages: MedicineMedicine (R0)